Drug Targets

CCL2, CXCL8, and CXCL12 orchestrate immune cell recruitment into tumors — why they matter for immuno-oncology research and which recombinant reagents you need.

EGFR, VEGFR, and FGFR drive tumor growth and angiogenesis — how growth factor signaling pathways shape cancer biology and which recombinant reagents support drug discovery.

From IL-2 to engineered IL-15 superagonists — how interleukins drive cancer immunotherapy and which recombinant reagents you need for drug discovery research.